Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis

BACKGROUND: In recent years, the U.S. government has designated funding of several large-scale initiatives for comparative effectiveness research (CER) in health care. The American Recovery and Reinvestment Act (ARRA) of 2009 apportioned more than $1 billion to support CER programs administered by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oderda, Gary M., Balfe, Lisa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442893/
https://www.ncbi.nlm.nih.gov/pubmed/22073936
http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442893/
https://www.ncbi.nlm.nih.gov/pubmed/22073936
http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S19

Ejemplares similares